Amipharm is focused on developing innovative medications based on phospholipid extracted from natural substances, specifically for cosmetic applications such as localized fat reduction
Amipharm is focused on developing innovative medications based on phospholipid extracted from natural substances, specifically for cosmetic applications such as localized fat reduction. Their flagship product, AYP-101, utilizes Soybean Phosphatidylcholine (SPC) to promote apoptosis and lipolysis in fat cells.